|Ms. Kimberly J. Popovits||Interim Chief Exec. Officer||12.82k||N/A||1959|
|Dr. Rustem F. Ismagilov Ph.D.||Co-Founder, Chairman of Scientific Advisory Board & Director||75k||N/A||1974|
|Mr. Douglas Liu||Chief Operating Officer||255.62k||N/A||1962|
|Mr. Brian Coe M.B.A.||Co-Founder & Advisor||377.49k||N/A||1969|
|Mr. Robert Kelley||Chief Commercial Officer||246.43k||N/A||1972|
|Mr. Liang Li Ph.D.||Co-Founder and Director of Technology & Strategy||N/A||N/A||N/A|
|Mr. J. Roger Moody Jr., M.B.A.||Chief Financial Officer||N/A||N/A||1968|
|Mr. J. Roger Moody||Chief Financial Officer||N/A||N/A||1968|
|Ms. Emily Faucette||Sr. VP of Corp. Communications & Investor Relations||N/A||N/A||N/A|
|Dr. Karen E. Flick J.D., Ph.D.||Chief of Staff & Sr. VP of Legal||N/A||N/A||1969|
Talis Biomedical Corporation operates as a molecular diagnostic company. It is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. The company is also developing Talis One assay kits for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A and influenza B plus SARS-CoV-2. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California.
Talis Biomedical Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.